20 Nov 2024 Compass Lexecon Client the City of Baltimore Awarded Over $260 Million after Jury Determines that Opioid Distributors’ Conduct Contributed to a Public Nuisance Healthcare & Life Sciences
18 Nov 2024 Compass Lexecon Client, The Federal Trade Commission, Granted Preliminary Injunction Pausing the Proposed Merger of Tapestry and Capri Retail
Insights abuse of dominance Search Search insight Filters Services… Antitrust & Competition Antitrust & Competition: Mergers Antitrust & Competition: Conduct Mergers & Acquisition Litigation Industries… Healthcare & Life Sciences abuse of dominance Clear all Showing 1–2 of 2 results Article • 31 Oct 2024 Guidelines without Guidance: Roundtable discussion on the draft Article 102 guidelines Article • 27 Aug 2024 GCR The Guide to Life Sciences: An Economist’s Perspective on Abuse of Dominance and Killer Acquisitions in the Pharma Industry
Article • 31 Oct 2024 Guidelines without Guidance: Roundtable discussion on the draft Article 102 guidelines
Article • 27 Aug 2024 GCR The Guide to Life Sciences: An Economist’s Perspective on Abuse of Dominance and Killer Acquisitions in the Pharma Industry